Literature DB >> 28185009

Relationship between the time to locoregional recurrence and survival in laryngeal squamous-cell carcinoma.

Philippe Gorphe1, Yungan Tao2, Pierre Blanchard2, Caroline Even3, Antoine Moya-Plana3, Haïtham Mirghani3, France Nguyen2, Stéphane Temam3, François Janot3.   

Abstract

To assess the relationship between the locoregional disease-free interval after treatment of the primary tumor and survival after a recurrence in patients with laryngeal carcinoma. We retrospectively investigated patients treated in our Cancer Center for a laryngeal cancer who subsequently developed a locoregional recurrence and were followed up until death. Post-recurrence survival was defined as the time from the locoregional recurrence to death. One hundred and twenty-three patients were included. Median post-recurrence survival was 7 months. The locoregional disease-free interval (LRDFI) after treatment of the primary was weakly correlated with post-recurrence survival (r = 0.210, p = 0.020). A LRDFI cut-off of 12 months was a significant prognostic factor (p = 0.005; median, 5 months, 95% CI: 2.239-6.761, vs 10 months, 95% CI: 7.270-12.730). The time to locoregional recurrence in laryngeal cancer was a prognostic factor correlated with post-recurrence survival. Locoregional failure within the first year after treatment of the primary tumor was associated with an unfavorable prognosis.

Entities:  

Keywords:  Disease-free interval; Laryngeal cancer; Locoregional recurrence; Survival

Mesh:

Year:  2017        PMID: 28185009     DOI: 10.1007/s00405-017-4473-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

1.  Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer.

Authors:  F Christopher Holsinger; Etai Funk; Dianna B Roberts; Eduardo M Diaz
Journal:  Head Neck       Date:  2006-09       Impact factor: 3.147

2.  Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.

Authors:  Takahide Taguchi; Goshi Nishimura; Masahiro Takahashi; Osamu Shiono; Masanori Komatsu; Daisuke Sano; Ken-Ichiro Yabuki; Yasuhiro Arai; Yukiko Yamashita; Kaoru Yamamoto; Yasunori Sakuma; Nobuhiko Oridate
Journal:  Int J Clin Oncol       Date:  2016-02-23       Impact factor: 3.402

3.  Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.

Authors:  Vlad C Sandulache; Laura J Vandelaar; Heath D Skinner; Juan Cata; Katherine Hutcheson; Clifton David Fuller; Jack Phan; Zuhair Siddiqui; Stephen Y Lai; Randal S Weber; Mark E Zafereo
Journal:  Head Neck       Date:  2016-02-16       Impact factor: 3.147

4.  Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trials.

Authors:  X Pivot; C Niyikiza; G Poissonnet; O Dassonville; R J Bensadoun; E Guardiola; C Foa; K Benezery; F Demard; A Thyss; M Schneider
Journal:  Oncology       Date:  2001       Impact factor: 2.935

5.  Vocal fold mobility as the main prognostic factor of treatment outcomes and survival in stage II squamous cell carcinomas of the glottic larynx.

Authors:  P Gorphe; P Blanchard; I Breuskin; S Temam; Y Tao; F Janot
Journal:  J Laryngol Otol       Date:  2015-07-23       Impact factor: 1.469

6.  Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?

Authors:  Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; I-How Chen; Shiang-Fu Huang; Ann-Joy Cheng; Tzu-Chen Yen
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

7.  Laryngeal cancer mortality trends in European countries.

Authors:  Liliane Chatenoud; Werner Garavello; Eleonora Pagan; Paola Bertuccio; Silvano Gallus; Carlo La Vecchia; Eva Negri; Cristina Bosetti
Journal:  Int J Cancer       Date:  2015-09-14       Impact factor: 7.396

8.  Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx.

Authors:  Philippe Gorphe; Pierre Blanchard; Stephane Temam; François Janot
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-14       Impact factor: 2.503

9.  Time to recurrence of squamous cell carcinoma of the head and neck.

Authors:  P M Stell
Journal:  Head Neck       Date:  1991 Jul-Aug       Impact factor: 3.147

10.  Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.

Authors:  David G Pfister; Kie-Kian Ang; David M Brizel; Barbara A Burtness; Paul M Busse; Jimmy J Caudell; Anthony J Cmelak; A Dimitrios Colevas; Frank Dunphy; David W Eisele; Jill Gilbert; Maura L Gillison; Robert I Haddad; Bruce H Haughey; Wesley L Hicks; Ying J Hitchcock; Merrill S Kies; William M Lydiatt; Ellie Maghami; Renato Martins; Thomas McCaffrey; Bharat B Mittal; Harlan A Pinto; John A Ridge; Sandeep Samant; David E Schuller; Jatin P Shah; Sharon Spencer; Randal S Weber; Gregory T Wolf; Frank Worden; Sue S Yom; Nicole R McMillian; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2013-08       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.